Brexpiprazole | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Brexpiprazole
US Exclusivities

PharmaCompass Sponsored Ads

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Brexpiprazole

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

50 API Suppliers, 21 USDMF, 6 EU WC, 1 KDMF, 10 NDC API, 36 Listed Suppliers, $ API Reference Price

50 API Suppliers
21 USDMF
6 EU WC
1 KDMF
10 NDC API
36 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

27 Drugs in Development

27 Drugs in Development

INTERMEDIATES

21 Intermediate Suppliers

21 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

118 FDF Dossiers, 91 FDA Orange Book, 6 Europe, 6 Canada, 4 Australia, 5 South Africa, 6 Listed Dossiers

118 FDF Dossiers
91 FDA Orange Book
6 Europe
6 Canada
4 Australia
5 South Africa
6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.25MG, TABLET;ORAL - 0.5MG, TABLET;ORAL - 1MG, TABLET;ORAL - 2MG, TABLET;ORAL - 3MG, TABLET;ORAL - 4MG

TABLET;ORAL - 0.25MG
TABLET;ORAL - 0.5MG
TABLET;ORAL - 1MG
TABLET;ORAL - 2MG
TABLET;ORAL - 3MG
TABLET;ORAL - 4MG

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 5 DKSH, 3 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Corel Pharma Chem, 4 DFE Pharma, 5 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 29 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 2 Vasa Pharmachem

4 SPI Pharma
5 DKSH
3 Faran Shimi Pharmaceutical
3 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 ACG Worldwide
1 Aeon Procare
5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
10 Corel Pharma Chem
4 DFE Pharma
5 Gangwal Chemicals
5 Ideal Cures Pvt Ltd
2 Ingredion Pharma Solutions
29 Kerry
3 Kima Chemical
6 Lonza Capsugel
10 Microlex e.U
1 Novo Excipients
1 Pharmatrans-Sanaq
3 Pluviaendo
2 Prachin Chemical
1 Qianhao Chemical (Hebei) Co., Ltd
1 Qualicaps
15 Roquette
7 Seppic
4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
10 Sigachi Industries
2 The Dow Chemical Company
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

51 Fillers, Diluents & Binders, 43 Coating Systems & Additives, 20 Controlled & Modified Release, 16 Direct Compression, 13 Thickeners and Stabilizers, 11 Lubricants & Glidants, 11 Granulation, 9 Co-Processed Excipients, 9 Disintegrants & Superdisintegrants, 7 Film Formers & Plasticizers, 7 Taste Masking, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 Coloring Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 3 API Stability Enhancers, 2 Emulsifying Agents, 1 Parenteral, 1 Solubilizers

51 Fillers, Diluents & Binders
43 Coating Systems & Additives
20 Controlled & Modified Release
16 Direct Compression
13 Thickeners and Stabilizers
11 Lubricants & Glidants
11 Granulation
9 Co-Processed Excipients
9 Disintegrants & Superdisintegrants
7 Film Formers & Plasticizers
7 Taste Masking
6 Chewable & Orodispersible Aids
5 Empty Capsules
5 Coloring Agents
4 Rheology Modifiers
4 Vegetarian Capsules
3 API Stability Enhancers
2 Emulsifying Agents
1 Parenteral
1 Solubilizers

DIGITAL CONTENT

55 News #PharmaBuzz

55 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 6 Regulatory FDF Prices, 16 Annual Reports

1 US Medicaid Prescriptions
6 Regulatory FDF Prices
16 Annual Reports

MARKET PLACE

10 APIs, 1 FDF Dossiers

10 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

88 US Patents, 24 US Exclusivities

88 US Patents
24 US Exclusivities

REF. STANDARDS & IMPURITIES

8 Others

8 Others

$ API Ref.Price (USD/KG) : 10,732 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

24 All

01 24OTSUKA

filter Product Reset all filters

24 All

01 24BREXPIPRAZOLE

filter Exclusivity Expiration Date Reset all filters

24 All

01 62026-05-10

02 62026-11-10

03 62027-05-08

04 62027-11-08

filter Exclusivity Code Reset all filters

24 All

01 6I-913

02 6M-14

03 12PED

Polpharma Brexpiprazole

Product Main Page

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-913

Exclusivity Expiration Date

2026-05-10

Application Number

205422

Product Number

3

Exclusivity Details

01

OTSUKA

Immuno-Oncology 360

Not Confirmed

OTSUKA

Japan

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : I-913

Exclusivity Expiration Date : 2026-05-10

Application Number : 205422

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-913

Exclusivity Expiration Date

2026-05-10

Application Number

205422

Product Number

4

Exclusivity Details

02

OTSUKA

Immuno-Oncology 360

Not Confirmed

OTSUKA

Japan

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : I-913

Exclusivity Expiration Date : 2026-05-10

Application Number : 205422

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-14

Exclusivity Expiration Date

2027-05-08

Application Number

205422

Product Number

4

Exclusivity Details

03

OTSUKA

Immuno-Oncology 360

Not Confirmed

OTSUKA

Japan

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : M-14

Exclusivity Expiration Date : 2027-05-08

Application Number : 205422

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-14

Exclusivity Expiration Date

2027-05-08

Application Number

205422

Product Number

3

Exclusivity Details

04

OTSUKA

Immuno-Oncology 360

Not Confirmed

OTSUKA

Japan

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : M-14

Exclusivity Expiration Date : 2027-05-08

Application Number : 205422

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-913

Exclusivity Expiration Date

2026-05-10

Application Number

205422

Product Number

5

Exclusivity Details

05

OTSUKA

Immuno-Oncology 360

Not Confirmed

OTSUKA

Japan

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : I-913

Exclusivity Expiration Date : 2026-05-10

Application Number : 205422

Product Number : 5

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-14

Exclusivity Expiration Date

2027-05-08

Application Number

205422

Product Number

5

Exclusivity Details

06

OTSUKA

Immuno-Oncology 360

Not Confirmed

OTSUKA

Japan

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : M-14

Exclusivity Expiration Date : 2027-05-08

Application Number : 205422

Product Number : 5

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-913

Exclusivity Expiration Date

2026-05-10

Application Number

205422

Product Number

6

Exclusivity Details

07

OTSUKA

Immuno-Oncology 360

Not Confirmed

OTSUKA

Japan

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : I-913

Exclusivity Expiration Date : 2026-05-10

Application Number : 205422

Product Number : 6

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-14

Exclusivity Expiration Date

2027-05-08

Application Number

205422

Product Number

6

Exclusivity Details

08

OTSUKA

Immuno-Oncology 360

Not Confirmed

OTSUKA

Japan

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : M-14

Exclusivity Expiration Date : 2027-05-08

Application Number : 205422

Product Number : 6

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-913

Exclusivity Expiration Date

2026-05-10

Application Number

205422

Product Number

1

Exclusivity Details

09

OTSUKA

Immuno-Oncology 360

Not Confirmed

OTSUKA

Japan

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : I-913

Exclusivity Expiration Date : 2026-05-10

Application Number : 205422

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-14

Exclusivity Expiration Date

2027-05-08

Application Number

205422

Product Number

1

Exclusivity Details

10

OTSUKA

Immuno-Oncology 360

Not Confirmed

OTSUKA

Japan

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : M-14

Exclusivity Expiration Date : 2027-05-08

Application Number : 205422

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!